| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 109,678 | 107,007 | 105,693 | 130,594 | | Cost of Revenue | 67,585 | 61,838 | 72,981 | 70,161 | | | Gross Profit | 42,093 | 45,169 | 32,712 | 60,433 | | | Operating Expenses | | Research Development | 10,427 | 10,032 | 10,209 | 10,767 | | Selling General and Administrative | 25,509 | 25,748 | 31,218 | 30,605 | | Non Recurring | 12,865 | 1,461 | 4,528 | 1,905 | | Others | 4,243 | 4,154 | 3,562 | 3,244 | | | | Total Operating Expenses | 53,044 | 41,395 | 49,517 | 46,521 | | | | Operating Income or Loss | (10,951) | 3,774 | (16,805) | 13,912 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (665) | 1,032 | 452 | 729 | | Earnings Before Interest And Taxes | (11,616) | 4,806 | (16,353) | 14,641 | | Interest Expense | 51 | 63 | 182 | 56 | | Income Before Tax | (11,667) | 4,743 | (16,535) | 14,585 | | Income Tax Expense | 19,595 | (3,100) | 77 | 1,377 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (31,262) | 7,843 | (16,612) | 13,208 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (31,262) | 7,843 | (16,612) | 13,208 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($31,262) | $7,843 | ($16,612) | $13,208 |
|
0.51% Nasdaq 
Income Statement
